Correlation Between Entero Therapeutics, and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and ZyVersa Therapeutics, you can compare the effects of market volatilities on Entero Therapeutics, and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and ZyVersa Therapeutics.
Diversification Opportunities for Entero Therapeutics, and ZyVersa Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Entero and ZyVersa is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Entero Therapeutics, and ZyVersa Therapeutics
Given the investment horizon of 90 days Entero Therapeutics, is expected to generate 0.83 times more return on investment than ZyVersa Therapeutics. However, Entero Therapeutics, is 1.21 times less risky than ZyVersa Therapeutics. It trades about -0.06 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 11,242 in Entero Therapeutics, on August 27, 2024 and sell it today you would lose (11,197) from holding Entero Therapeutics, or give up 99.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entero Therapeutics, vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Entero Therapeutics, |
| ZyVersa Therapeutics |
Entero Therapeutics, and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entero Therapeutics, and ZyVersa Therapeutics
The main advantage of trading using opposite Entero Therapeutics, and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Entero Therapeutics, vs. Nextplat Corp | Entero Therapeutics, vs. Space Communication | Entero Therapeutics, vs. Cedar Realty Trust | Entero Therapeutics, vs. Getty Realty |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges |